Atlas Trials

Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants.

Clinical trial NCT03714568 · UNKNOWN

Trial details

NCT number
NCT03714568
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetic
Start date
2018-11-11
Primary completion
2019-09-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.